Budapest, Hungary

János Szulágyi

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Budapesti Vegyimuvek, Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag, Egis Gyogyszergyar Rt.. Active years: 1989-2013.

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 9.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1989-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: János Szulágyi: Innovator in Pharmaceutical Processes

Introduction

János Szulágyi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of pharmaceutical intermediates. With a total of 3 patents, his work has implications for the development of important therapeutic agents.

Latest Patents

Szulágyi's latest patents include a process for the preparation of cyclopropyl benzyl ketone compounds. This invention involves the reaction of a Grignard reagent with specific compounds, leading to intermediates that are crucial in the synthesis of prasugrel, a platelet inhibitor used in therapy. His second patent details a process for preparing a complex compound, which involves ring-closure reactions in the presence of various bases. This method allows for the economical production of pharmaceutical products with high purity.

Career Highlights

Throughout his career, Szulágyi has worked with prominent companies in the pharmaceutical industry, including Egis Gyógyszergyár Rt. and Egis Gyógyszergyar Nyilvanosan Mukodo Reszvenytarsasag. His expertise in pharmaceutical processes has positioned him as a valuable asset in the field.

Collaborations

Szulágyi has collaborated with notable colleagues such as László Pongó and József Reiter. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

János Szulágyi's contributions to pharmaceutical processes highlight his role as an innovator in the field. His patents reflect a commitment to improving therapeutic agents and advancing pharmaceutical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…